首页|清热利湿止血汤治疗湿热内蕴型肾小球源性血尿患者疗效及对尿隐血红细胞计数水平的影响

清热利湿止血汤治疗湿热内蕴型肾小球源性血尿患者疗效及对尿隐血红细胞计数水平的影响

扫码查看
目的 探讨清热利湿止血汤治疗湿热内蕴型肾小球源性血尿患者疗效及对尿隐血、红细胞计数水平的影响。方法 选取2021年9月至2023年9月在浙江省丽水市人民医院确诊的160例肾小球源性血尿患者,按治疗方法分为治疗组(80例)和对照组(80例)。对照组采用西医常规治疗方案,治疗组在对照组基础上采用清热利湿止血汤,均治疗3个月。比较2组患者的中医证候积分、疗效、不良反应发生情况,在治疗前后比较2组患者尿隐血、红细胞、尿蛋白定量(24 h)、离心红细胞情况。结果 治疗后,关于尿道灼痛、腰酸腹胀、足心灼热中医证候评分,治疗组得分分别为(0。84±0。13)分、(0。74±0。19)分、(1。05±0。26)分,对照组得分分别为(1。15±0。18)分、(1。38±0。22)分、(1。34±0。31)分,2组得分均低于治疗前,且治疗组低于对照组(P<0。05);治疗后,治疗组有效率93%高于对照组81%(P<0。05);治疗后,治疗组红细胞计数、离心红细胞数量、尿蛋白定量(24 h)分别为(195±42)个/µl、(13±3)个/HP、(0。58±0。24)g/24 h,对照组分别为(220±52)个/μl、(16±4)个/HP、(0。73±0。31)g/24 h,2组均低于治疗前,且治疗组低于对照组(P<0。05);治疗后,治疗组尿隐血(++++)、(+++)、(++)例数低于对照组,(+)、(-)例数高于对照组(P<0。05);治疗后,治疗组不良反应发生率4%,对照组11%,2组差异无统计学意义(P>0。05)。结论 清热利湿止血汤可以改善湿热内蕴型肾小球源性血尿的血尿症状,降低尿隐血、红细胞水平,具有良好的临床疗效。
Curative effect of Qingre Lishi Zhixue Decoction and its influences on levels of urine BLD and RBC in patients with glomerular-derived hematuria of damp-heat accumulation type
Objective To explore the curative effect of Qingre Lishi Zhixue Decoction and its influences on levels of urine latent blood(BLD)and red blood cells(RBC)in patients with glomerular-derived hematuria of damp-heat accumulation type.Methods A total of 160 patients with glomerular-derived hematuria confirmed in Lishui People's Hospital were enrolled between September 2021 and September 2023.According to treatment method,they were divided into a treatment group(n=80)and a control group(n=80).The control group was treated with routine therapeutic regimen,while the treatment group was additionally treated with Qingre Lishi Zhixue Decoction.All were treated for 3 months.The scores of TCM syndromes,curative effect and occurrence of adverse reactions,BLD,RBC,24 h urinary protein quantification and centrifugal RBC before and after treatment were compared between the two groups.Results After treatment,scores of TCM syndromes(urethral burning pain,soreness of waist and abdominal distension,sole centre burning)in both groups were decreased,which were lower in treatment group than control group[(0.84±0.13)points,(0.74±0.19)points,(1.05±0.26)points vs(1.15±0.18)points,(1.38±0.22)points,(1.34±0.31)points;P<0.05];Response rate of treatment group was higher than that of control group(93%vs 81%,P<0.05);RBC,number of centrifugal RBC and 24 h urinary protein quantification were reduced in both groups,which were lower in treatment group than control group[(195±42)/μl,(13±3)/HP,(0.58±0.24)g/24 h vs(220±52)/μl,(16±4)/HP,(0.73±0.31)g/24 h;P<0.05];Number of cases with BLD(++++),(+++)and(++)in treatment group was less than that in control group,while number of cases with BLD(+)and(-)was more than that in control group(P<0.05);There was no significant difference in the occurrence of adverse reactions between the two groups(4%vs 11%,P>0.05).Conclusion Qingre Lishi Zhixue Decoction can improve hematuria symptoms,reduce levels of urine BLD and RBC in glomerular-derived hematuria of damp-heat accumulation type,with good clinical curative effect.

Clear heat and dissolving damnpnessErythrocytes,Qing Re Li shi Zhi Xue TangDamp-heat accumulation typeGlomerular-derived hematuriaUrine latent blood

孟金玲、桂志红、吴凌慧、金菊

展开 >

浙江中医药大学研究生院,浙江杭州 310053

丽水市人民医院肾内科,浙江丽水 323000

清热祛湿 红细胞 清热湿止血汤 湿热内蕴型 肾小球源性血尿 尿隐血

2024

中国药物与临床
中国医院协会

中国药物与临床

影响因子:0.846
ISSN:1671-2560
年,卷(期):2024.24(7)